1
|
Al‐Soufi L, Martorell L, Moltó M, González‐Peñas J, García‐Portilla MP, Arrojo M, Rivero O, Gutiérrez‐Zotes A, Nácher J, Muntané G, Paz E, Páramo M, Bobes J, Arango C, Sanjuan J, Vilella E, Costas J. A polygenic approach to the association between smoking and schizophrenia. Addict Biol 2022; 27:e13104. [PMID: 34779080 DOI: 10.1111/adb.13104] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Revised: 08/18/2021] [Accepted: 09/20/2021] [Indexed: 11/30/2022]
Abstract
Smoking prevalence in schizophrenia is considerably larger than in general population, playing an important role in early mortality. We compared the polygenic contribution to smoking in schizophrenic patients and controls to assess if genetic factors may explain the different prevalence. Polygenic risk scores (PRSs) for smoking initiation and four genetically correlated traits were calculated in 1108 schizophrenic patients (64.4% smokers) and 1584 controls (31.1% smokers). PRSs for smoking initiation, educational attainment, body mass index and age at first birth were associated with smoking in patients and controls, explaining a similar percentage of variance in both groups. Attention-deficit hyperactivity disorder (ADHD) PRS was associated with smoking only in schizophrenia. This association remained significant after adjustment by psychiatric cross-disorder PRS. A PRS combining all the traits was more explanative than smoking initiation PRS alone, indicating that genetic susceptibility to the other traits plays an additional role in smoking behaviour. Smoking initiation PRS was also associated with schizophrenia in the whole sample, but the significance was lost after adjustment for smoking status. This same pattern was observed in the analysis of specific SNPs at the CHRNA5-CHRNA3-CHRNB4 cluster associated with both traits. Overall, the results indicate that the same genetic factors are involved in smoking susceptibility in schizophrenia and in general population and are compatible with smoking acting, directly or indirectly, as a risk factor for schizophrenia that contributes to the high prevalence of smoking in these patients. The contrasting results for ADHD PRS may be related to higher ADHD symptomatology in schizophrenic patients.
Collapse
Affiliation(s)
- Laila Al‐Soufi
- Psychiatric Genetics Group Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Santiago de Compostela Spain
- Department of Zoology, Genetics and Physical Anthropology Universidade de Santiago de Compostela (USC) Santiago de Compostela Spain
| | - Lourdes Martorell
- Hospital Universitari Institut Pere Mata (HUIPM); Institut d'Investigació Sanitària Pere Virgili (IISPV); Universitat Rovira i Virgili (URV) Reus Spain
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
| | - M.Dolores Moltó
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
- INCLIVA Biomedical Research Institute Fundación Investigación Hospital Clínico de Valencia Valencia Spain
- Department of Genetics Universitat de València Valencia Spain
| | - Javier González‐Peñas
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) Madrid Spain
| | - Ma Paz García‐Portilla
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
- Department of Psychiatry, Universidad de Oviedo; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA); Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA); Servicio de Salud del Principado de Asturias (SESPA) Oviedo Spain
| | - Manuel Arrojo
- Psychiatric Genetics Group Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Santiago de Compostela Spain
- Servizo de Psiquiatría, Complexo Hospitalario Universitario de Santiago de Compostela Servizo Galego de Saúde (SERGAS) Santiago de Compostela Spain
| | - Olga Rivero
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
- INCLIVA Biomedical Research Institute Fundación Investigación Hospital Clínico de Valencia Valencia Spain
- Department of Genetics Universitat de València Valencia Spain
| | - Alfonso Gutiérrez‐Zotes
- Hospital Universitari Institut Pere Mata (HUIPM); Institut d'Investigació Sanitària Pere Virgili (IISPV); Universitat Rovira i Virgili (URV) Reus Spain
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
| | - Juan Nácher
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
- INCLIVA Biomedical Research Institute Fundación Investigación Hospital Clínico de Valencia Valencia Spain
- Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED) Universitat de València Valencia Spain
| | - Gerard Muntané
- Hospital Universitari Institut Pere Mata (HUIPM); Institut d'Investigació Sanitària Pere Virgili (IISPV); Universitat Rovira i Virgili (URV) Reus Spain
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
| | - Eduardo Paz
- Psychiatric Genetics Group Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Santiago de Compostela Spain
- Servizo de Psiquiatría, Complexo Hospitalario Universitario de Santiago de Compostela Servizo Galego de Saúde (SERGAS) Santiago de Compostela Spain
| | - Mario Páramo
- Psychiatric Genetics Group Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Santiago de Compostela Spain
- Servizo de Psiquiatría, Complexo Hospitalario Universitario de Santiago de Compostela Servizo Galego de Saúde (SERGAS) Santiago de Compostela Spain
| | - Julio Bobes
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
- Department of Psychiatry, Universidad de Oviedo; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA); Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA); Servicio de Salud del Principado de Asturias (SESPA) Oviedo Spain
| | - Celso Arango
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) Madrid Spain
| | - Julio Sanjuan
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
- INCLIVA Biomedical Research Institute Fundación Investigación Hospital Clínico de Valencia Valencia Spain
- Department of Psychiatric, School of Medicine Universitat de València Valencia Spain
| | - Elisabet Vilella
- Hospital Universitari Institut Pere Mata (HUIPM); Institut d'Investigació Sanitària Pere Virgili (IISPV); Universitat Rovira i Virgili (URV) Reus Spain
- Spanish Mental Health Research Network (CIBERSAM) Madrid Spain
| | - Javier Costas
- Psychiatric Genetics Group Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Santiago de Compostela Spain
- Servizo Galego de Saúde (SERGAS) Complexo Hospitalario Universitario de Santiago de Compostela (CHUS) Santiago de Compostela Spain
| |
Collapse
|
2
|
Mas S, Gassó P, Rodríguez N, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Castro-Fornieles J, Bobes J, Usall J, Saiz-Ruiz J, Contreras F, Parellada E, Bernardo M, Bioque M, Diaz‐Caneja CM, González‐Peñas J, Solis AA, Rebella M, González‐Ortega I, Besga A, SanJuan J, Nacher J, Morro L, Montserrat C, Jimenez E, Costa SGD, Baeza I, de la Serna E, Rivas S, Diaz C, Saiz PA, Garcia‐Álvarez L, Fraile MG, Rabadán AZ, Torio I, Rodríguez‐Jimenez R, Butjosa A, Pardo M, Sarró S, Pomarol‐Clotet E, Cuadrado AI, Cuesta MJ. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort. Acta Psychiatr Scand 2020; 141:541-552. [PMID: 31746462 DOI: 10.1111/acps.13131] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/30/2019] [Revised: 09/16/2019] [Accepted: 11/17/2019] [Indexed: 12/29/2022]
Abstract
AIMS Here, we present a clustering strategy to identify phenotypes of antipsychotic (AP) response by using longitudinal data from patients presenting first-episode psychosis (FEP). METHOD One hundred and ninety FEP with complete data were selected from the PEPs project. The efficacy was assessed using total PANSS, and adverse effects using total UKU, during one-year follow-up. We used the Klm3D method to cluster longitudinal data. RESULTS We identified four clusters: cluster A, drug not toxic and beneficial; cluster B, drug beneficial but toxic; cluster C, drug neither toxic nor beneficial; and cluster D, drug toxic and not beneficial. These groups significantly differ in baseline demographics, clinical, and neuropsychological characteristics (PAS, total PANSS, DUP, insight, pIQ, age of onset, cocaine use and family history of mental illness). CONCLUSIONS The results presented here allow the identification of phenotypes of AP response that differ in well-known simple and classic clinical variables opening the door to clinical prediction and application of personalized medicine.
Collapse
Affiliation(s)
- S Mas
- Pharmacology Unit, Department of Clinical Foundations, University of Barcelona, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain
| | - P Gassó
- Pharmacology Unit, Department of Clinical Foundations, University of Barcelona, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain
| | - N Rodríguez
- Fundació Clinic per la Recerca Biomédica (FCRB), Barcelona, Spain
| | - B Cabrera
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Barcelona Clínic Schizophrenia Unit, Neuroscience Institute Hospital Clínic de Barcelona, Barcelona, Spain
| | - G Mezquida
- Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Barcelona, Spain.,Fundació Clínic per la Recerca Biomèdica (FCRB), Department of Clinical Foundations, Pharmacology Unit, University of Barcelona, Barcelona, Spain
| | - A Lobo
- Department of Medicine and Psychiatry, University of Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain
| | - A González-Pinto
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Department of Psychiatry, Hospital Universitario de Alava, Vitoria, Spain.,BIOARABA Health Research Institute, Vitoria, Spain.,University of the Basque Country, Vitoria, Spain
| | - M Parellada
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain
| | - I Corripio
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Servicio de Psiquiatría, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.,Instituto de Investigación Biomédica Sant Pau (IIB-SANT PAU), Barcelona, Spain.,Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
| | - E Vieta
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Hospital Clínic de Barcelona, Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain
| | - J Castro-Fornieles
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Child and Adolescent Psychiatry and Psychology Department, 2017SGR881, Institute Clinic of Neurosciences, Hospital Clinic of Barcelona, Barcelona, Spain
| | - J Bobes
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Área de Psiquiatría, Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Asturias, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain
| | - J Usall
- Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.,Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain
| | - J Saiz-Ruiz
- Hospital Ramon y Cajal, Universidad de Alcala, IRYCIS, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
| | - F Contreras
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Psychiatric Service, Bellvitge University Hospital, Hospitalet del Llobregat, Spain.,University of Barcelona, Barcelona, Spain
| | - E Parellada
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain
| | - M Bernardo
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Barcelona Clínic Schizophrenia Unit, Neuroscience Institute, Hospital Clínic of Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|